LIFESCIENCE
INNOVATION
GOOD HEALTHCARE
TECHNOLOGY
Let's shine a light together on the new generation of health technologies based on reliable and ethical AI, from Biopharmaceuticals to Digital Health.
#AI #Biopharmaceutics #DigitalHealthcare #EthicsAI
LIFESCIENCE
INNOVATION
GOOD HEALTHCARE
TECHNOLOGY
Illuminiamo assieme la strada verso una nuova generazione di tecnologie per la Salute basate su AI affidabile ed etica, dalla Biofarmaceutica alla Sanita' Digitale.
#AI #Biopharmaceutics #DigitalHealthcare #EthicsAI
Partners
About
LIGHT – Lifescience Innovation Good Healthcare Technology – is a new technological infrastructure for operational innovation in the fields of Artificial Intelligence, Biopharmaceuticals, and Digital Health Care. It was established by the University of Brescia in collaboration with companies Dompè Farmaceutici S.p.A., an Italian leader in the biopharmaceutical sector, and Antares Vision Group, an Italian multinational leader in traceability and quality control of products and supply chains. The project is based on a public-private partnership that has raised €19.5 million in funds and won funding from the Ministry of University and Research through the use of funds from the PNRR, Innovation Infrastructure Grant.
Goal
To combine and expand existing technological resources to create a new infrastructure open to researchers and companies, consisting of 3 hubs.
Methods
To pool tools and know-how from universities and industrial research in order to provide services and resources to accelerate the testing of reliable AI in Biopharma & Digital Health, developing national and international innovation projects and synergies for health based on ethical and safe AI.
Results
Expected outcomes include Innovation Projects, New Products, the construction of a network of laboratories, the development of Open Science initiatives, the formation of multidisciplinary teams, and support for training in AI Digital skills for Health.
Laboratory Locations
LIGHT is based in a central location in Brescia, which expands and modernizes the laboratories of the Multisectoral and Technological Service Center S.R.L. (CSMT), and supports interventions in operational locations of Travagliato (BS), L’Aquila, and Naples.
Board of Directors
President: Marina Pizzi
Members:
- Marcello Allegretti
- Elisabetta Ceretti
- Adriano Fusco
- Emidio Zorzella
Director (Infrastructure Manager): Cesare Furlanello
Hubs
Innovative technological infrastructure, with widespread localization
AI and Big Data Main Hub
High-performance computational infrastructure for Data mining, Machine learning and other AI technologies for predictive medicine.
Digital Health Care Hub
Development of advanced technologies for The Hospital of the Future, Telemedicine, Patient well-being.
AI Biopharma Hub
Laboratory focused on Design, Development, Characterization of new drugs using AI technologies.
News
La sfida dell’accreditamento nelle biobanche
La sfida dell’accreditamento nelle biobanche (ISO 20387): Nuovi paradigmi di tracciabilità e rintracciabilità a sostegno di sicurezza, efficienza, e sostenibilità
LIGHT Thematic Workshop May 15, 2024 “Artificial intelligence and health data management”
Venue: Room F – Faculty of Medicine Central Building (mezzanine floor, block E) – Viale Europa 11, University of Brescia
LIGHT Thematic Workshop22 September 2023 “AI: new opportunities and challenges for Drug Discovery,Repurposing and Toxicology”
Venue: Aula A – Edificio Centrale di Medicina -Viale Europa 11 Universita’ degli Studi di Brescia Time: 14:30-16:00 Speechs: Introduction
UniBs, Antares Vision, and Dompé Farmaceutici sign the articles of association of the LIGHT S.c.ar.l Company
On Monday, January 30, 2023, the University of Brescia, Antares Vision Spa, and Dompé Pharmaceuticals Spa established the company “Lifescience
L.I.G.H.T. – Lifescience Innovation Good Healthcare Technology: 2,000 sqm in the Unibs Campus for Developing the Hospital and Healthcare of the Future
The University of Brescia has signed an agreement with Antares Vision Group, an Italian multinational leader in traceability and quality